铁亡,热亡和死亡中的长非编码RNA:从功能到癌症治疗中的临床含义
1School of Basic Medicine, Yangtze University, Health Science Center, Yangtze University, Jingzhou, Hubei, China.
Frontiers in oncology
|September 13, 2024
概括
长非编码RNAs (lncRNAs) 调节癌症中的非亡细胞死亡途径,为个性化癌症干预提供生物标志物和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 全球人口老龄化增加了癌症发病率,使其成为死亡的主要原因.
- 长非编码RNAs (lncRNAs) 是基因表达和细胞过程的关键调节者,包括癌细胞生长和死亡.
- 非亡调节细胞死亡 (RCD) 途径,如铁亡,热亡和死亡,显著影响癌症的进展.
研究的目的:
- 审查 lncRNAs 在癌症中调节非亡性 RCD 的机制.
- 突出 lncRNAs 作为癌症诊断和预后的生物标志物的潜力.
- 探索在癌症治疗中准 lncRNAs 的治疗影响.
主要方法:
- 对研究 lncRNAs 和癌症中非细胞死亡的研究进行文献综述.
- 分析了基底的分子机制 lncRNA介导调节的铁灭,热灭和死灭.
- 对各种癌症类型的lncRNA生物标记物的当前知识的综合.
主要成果:
- lncRNAs参与调节癌细胞中的多个非亡性RCD通路.
- lncRNAs的失调可以促进或抑制癌细胞死亡,影响癌细胞的增殖,入侵和转移.
- 特定的 lncRNAs 显示为不同癌症的诊断和预后生物标志物具有前途.
结论:
- 了解lncRNA在非亡细胞死亡中的作用,对于推进癌症治疗至关重要.
- 调节lncRNA表达是一种新型癌症治疗的有希望的策略.
- lncRNAs提供了基于细胞死亡途径调节的个性化癌症干预开发的潜力.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
199
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:16Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
01:30Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K